The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
Open accessAbstract
Lung premalignancy and early-stage adenocarcinoma use a mechanism of glucose transport that can be targeted for early diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“But an alternative tracer, methyl-4-deoxy-4-[18F]-fluoro-α-d-glucopyranoside (Me4FDG), is taken up by SGLT and can identify AAH and low-grade adenocarcinomas of the lung (24).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [24]
In the citing paper
“In atypical adenomatous hyperplasias (AAHs) of the lung, premalignant lesions overexpress sodium-dependent glucose transporter 2 (SGLT2).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E. M., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Đačić, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,532
Benefits and Harms of CT Screening for Lung Cancer
Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., Byers, T., Colditz, G. A., Gould, M. K., Jett, J. R., et al. (2012) · JAMA · doi:10.1001/jama.2012.5521 · Cited by 1,237
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. Ο. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,185
AMIDE: A Free Software Tool for Multimodality Medical Image Analysis
Loening, A. M., & Gambhir, S. S. (2003) · Molecular Imaging · doi:10.1162/153535003322556877 · Cited by 967
Bailey, C. J., Gross, J. L., Pieters, A., Bastien, A., & List, J. F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60407-2 · Cited by 873
Regulation of glut1 mRNA by Hypoxia-inducible Factor-1
Chen, C., Pore, N., Behrooz, A., Ismail‐Beigi, F., & Maity, A. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010144200 · Cited by 769
Recent Trends in the Identification of Incidental Pulmonary Nodules
Gould, M. K., Tang, T., Liu, I. A., Lee, J. S., Zheng, C., Danforth, K. N., Kosco, A. E., Fiore, J. L. D., & Suh, D. E. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0990oc · Cited by 748
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
Ganapathy, V., Thangaraju, M., & Prasad, P. D. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.005 · Cited by 724
Travis, W. D., Brambilla, E. M., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Powell, C. A., Beer, D. G., Riely, G. J., Garg, K., et al. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201107-042st · Cited by 587
Shackelford, D. B., Abt, E., Gerken, L., Vasquez, D. S., Seki, A., Leblanc, M., Wei, L., Fishbein, M. C., Czernin, J., Mischel, P. S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.008 · Cited by 585
Self-citationResults of the Two Incidence Screenings in the National Lung Screening Trial
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208962 · Cited by 540
Self-citationGlucose transporters in cancer metabolism
Adekola, K., Rosen, S. T., & Shanmugam, M. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328356da72 · Cited by 382
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Higashi, K., Ueda, Y., Seki, H., Yuasa, K., Oguchi, M., Noguchi, T., Taniguchi, M., Tonami, H., Okimura, T., & Yamamoto, I. (1998) · PubMed · Cited by 351
Functional expression of sodium-glucose transporters in cancer
Scafoglio, C., Hirayama, B. A., Kepe, V., Liu, J., Ghezzi, C., Satyamurthy, N., Moatamed, N. A., Huang, J., Koepsell, H., Barrio, J. R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511698112 · Cited by 343
Self-citationNatural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low-Dose CT Scan
Chang, B., Hwang, J. H., Choi, Y., Chung, M. P., Kim, H., Kwon, O., Lee, H. Y., Lee, K. S., Shim, Y. M., Han, J., et al. (2013) · CHEST Journal · doi:10.1378/chest.11-2501 · Cited by 278
Mamede, M. H., Higashi, T., Kitaichi, M., Ishizu, K., Ishimori, T., Nakamoto, Y., Yanagihara, K., Li, M., Tanaka, F., Wada, H., et al. (2005) · Neoplasia · doi:10.1593/neo.04577 · Cited by 231
Vansteenkiste, J., Fischer, B. M., Dooms, C., & Mortensen, J. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01564-5 · Cited by 231
Devineni, D., Curtin, C. R., Polidori, D., Gutierrez, M. J., Murphy, J., Rusch, S., & Rothenberg, P. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.88 · Cited by 216
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
Shackelford, D. B., Vasquez, D. S., Corbeil, J., Wu, S., Leblanc, M., Wu, C., Vera, D. R., & Shaw, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900465106 · Cited by 215
Self-citationPure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management
Lee, H. Y., Choi, Y., Lee, K. S., Han, J., Zo, J. I., Shim, Y. M., & Moon, J. W. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11819 · Cited by 205
Biological correlates of FDG uptake in non-small cell lung cancer
de Geus‐Oei, L., van Krieken, J. H., Aliredjo, R. P., Krabbe, P. F. M., Frielink, C., Verhagen, A. F. T. M., Boerman, O. C., & Oyen, W. J. G. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.08.018 · Cited by 193
PET/CT imaging in different types of lung cancer: An overview
Ambrosini, V., Nicolini, S., Caroli, P., Nanni, C., Massaro, A., Marzola, M. C., Rubello, D., & Fanti, S. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.03.020 · Cited by 191
AMIDE: A Free Software Tool for Multimodality Medical Image Analysis
Loening, A., & Gambhir, S. (2003) · Molecular Imaging · doi:10.1162/15353500200303133 · Cited by 161
Goodwin, J., Neugent, M. L., Lee, S. Y., Choe, J. H., Choi, H., Jenkins, D. M. R., Ruthenborg, R. J., Robinson, M. W., Jeong, J. Y., Wake, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15503 · Cited by 158
Self-citationPrecancer Atlas to Drive Precision Prevention Trials
Spira, A. E., Yurgelun, M. B. B., Alexandrov, L. B., Rao, A., Bejar, R., Polyák, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 134
Do all lung adenocarcinomas follow a stepwise progression?
Yatabe, Y., Borczuk, A., & Powell, C. A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.021 · Cited by 127
van den Bergh, K. A. M., Essink‐Bot, M., Bunge, E. M., Scholten, E. T., Prokop, M., van Iersel, C. A., van Klaveren, R. J., & de Koning, H. J. (2008) · Cancer · doi:10.1002/cncr.23590 · Cited by 126
Regional distribution of SGLT activity in rat brain in vivo
Yu, A. S., Hirayama, B. A., Timbol, G., Liu, J., Diez-Sampedro, A., Kepe, V., Satyamurthy, N., Huang, S.-C., Wright, E. M., & Barrio, J. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2012 · Cited by 126
Self-citationFunctional expression of SGLTs in rat brain
Yu, A. S., Hirayama, B. A., Timbol, G., Liu, J., Basarah, E., Kepe, V., Satyamurthy, N., Huang, S., Wright, E. M., & Barrio, J. R. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2010 · Cited by 123
Self-citationGenomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma
Sivakumar, S., Lucas, F. A. S., McDowell, T. L., Lang, W., Li, X., Fujimoto, J., Zhang, J. J., Futreal, P. A., Fukuoka, J., Yatabe, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1605 · Cited by 123
Self-citationImmune checkpoint inhibitors in advanced non–small cell lung cancer
Assi, H. I., Kamphorst, A. O., Moukalled, N. M., & Ramalingam, S. S. (2017) · Cancer · doi:10.1002/cncr.31105 · Cited by 123
FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
Yap, C., Schiepers, C. W., Fishbein, M. C., Phelps, M. E., & Czernin, J. G. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0853-y · Cited by 121
SGLT Gene Expression in Primary Lung Cancers and Their Metastatic Lesions
Ishikawa, N., Oguri, T., Isobe, T., Fujitaka, K., & Kohno, N. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01175.x · Cited by 119
Kobayashi, Y., & Mitsudomi, T. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.09.03 · Cited by 118
Blackburn, E. H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0195 · Cited by 105
Takahashi, R., Hirata, H., Tachibana, I., Shimosegawa, E., Inoue, A., Nagatomo, I., Takeda, Y., Kida, H., Goya, S., Kijima, T., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0868 · Cited by 91
Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice
Sala‐Rabanal, M., Hirayama, B. A., Ghezzi, C., Liu, J., Huang, S., Kepe, V., Koepsell, H., Yu, A. S., Powell, D. R., Thorens, B., et al. (2016) · The Journal of Physiology · doi:10.1113/jp271904 · Cited by 91
Self-citationSha, S., Polidori, D., Farrell, K., Ghosh, A., Natarajan, J., Vaccaro, N. M., Pinheiro, J. C., Rothenberg, P., & Plum‐Mörschel, L. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12418 · Cited by 88
Ooi, A. T., Gower, A. C., Zhang, K. X., Vick, J. L., Hong, L., Nagao, B., Wallace, W. D., Elashoff, D. A., Walser, T. C., Dubinett, S. M., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0372 · Cited by 81
Self-citationPulmonary adenocarcinoma: A renewed entity in 2011
Kadara, H. N., Kabbout, M., & Wistuba, I. I. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02095.x · Cited by 78
Suzawa, N., Ito, M., Qiao, S., Uchida, K., Takao, M., Yamada, T., Takeda, K., & Murashima, S. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.08.017 · Cited by 74
Early lung cancer with lepidic pattern
Weichert, W., & Warth, A. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000065 · Cited by 72
Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule
Ghezzi, C., Yu, A. S., Hirayama, B. A., Kepe, V., Liu, J., Scafoglio, C., Powell, D. R., Huang, S., Satyamurthy, N., Barrio, J. R., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050510 · Cited by 72
Self-citationCancer Prevention and Interception: A New Era for Chemopreventive Approaches
Albini, A., DeCensi, A., Cavalli, F., & Costa, A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0695 · Cited by 56
Bao, Q., & Chatziioannou, A. F. (2010) · Medical Physics · doi:10.1118/1.3495817 · Cited by 53
Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas
Kepe, V., Scafoglio, C., Liu, J., Yong, W. H., Bergsneider, M., Huang, S., Barrio, J. R., & Wright, E. M. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2823-7 · Cited by 38
Self-citationImmune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer
Remón, J., & Besse, B. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000351 · Cited by 34
Ho, K., Fang, Y.-H. D., Chung, H., Liu, Y.-C., Chang, J. W., Hou, M., Yang, C., Cheng, N.-M., Su, T.-P., & Yen, T. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3433-2 · Cited by 30
Molecular Characterization of the Peripheral Airway Field of Cancerization in Lung Adenocarcinoma
Tsay, J.-C. J., Li, Z., Yie, T.-A., Wu, F. C., Segal, L. N., Greenberg, A. K., Leibert, E. M., Weiden, M. D., Pass, H. I., Munger, J. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118132 · Cited by 27
Wu, H., Wang, L., Wang, Q., Han, Y.-J., Li, H., Zhou, W., & Tian, Y. (2015) · BioMed Research International · doi:10.1155/2015/243681 · Cited by 22
Positron emission tomography in bronchioloalveolar carcinoma of the lung
Huang, T.-W., Lin, L., Hsieh, C.-M., Cheng, Y., Chang, H., Tzao, C., & Lee, S.-C. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.08.020 · Cited by 5
Research works printed but not linked: 1
- L. C. Horn L D. H. Johnson Neoplasms of the Lung in Harrison’s Principles of Internal Medicine D. Kasper A. Fauci S. Hauser D. Longo J. Jameson J. Loscalzo Eds. (McGraw-Hill ed. 19 2015); http://accessmedicine.mhmedical.com/content.aspx?bookid=1130&Sectionid=69857702.
Cited by
Sorted by citations
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Mitochondrial Metabolism as a Target for Cancer Therapy
Vasan, K., Werner, M., & Chandel, N. S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.019 · Cited by 762
Li, J., Liu, H., Takagi, S., Nitta, K., Kitada, M., Srivastava, S. P., Takagaki, Y., Kanasaki, K., & Koya, D. (2020) · JCI Insight · doi:10.1172/jci.insight.129034 · Cited by 246
Glucose Transporters as a Target for Anticancer Therapy
Pliszka, M., & Szablewski, L. (2021) · Cancers · doi:10.3390/cancers13164184 · Cited by 214
Gongora, C. A., Drobni, Z. D., Silva, T. Q. A. C., Zafar, A., Gong, J., Zlotoff, D. A., Gilman, H. K., Hartmann, S. E., Sama, S., Nikolaidou, S., et al. (2022) · JACC Heart Failure · doi:10.1016/j.jchf.2022.03.006 · Cited by 161
Metadata
- Authors
- Scafoglio, C. R., Villegas, B., Abdelhady, G., Bailey, S. T., Liu, J., Shirali, A. S., Wallace, W. D., Magyar, C. E., Grogan, T. R., Elashoff, D., Walser, T., Yanagawa, J., Aberle, D. R., Barrio, J. R., Dubinett, S. M., & Shackelford, D. B.
- Affiliations
- University of California, Los Angeles (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Scafoglio, Claudio R.
- Shackelford, David B.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2018-11-14
- Volume
- 10
- Issue
- 467
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC6428683
- OpenAlex
- W2901781577
- Cited by
- 176
- References
- 55
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 35 · 2023: 17 · 2022: 22 · 2021: 29 · 2020: 15 · 2019: 14 · 2018: 1
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Cancer Society (130696-RSG-17-003-01-CCE)
- Tobacco-Related Disease Research Program (26IR-0009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Keywords
- SGLT2, lung adenocarcinoma, early-stage lung cancer, SGLT2 inhibitors, tumor growth inhibition, patient-derived xenografts, autochthonous mouse model, diagnostic imaging, therapeutic target
- MeSH terms
- Adenocarcinoma of Lung, Sodium-Glucose Transporter 2 Inhibitors, Aged, Aged, 80 and over, Animals, Biological Transport, Cell Differentiation, Female, Glucose, Humans, Male, Mice, Transgenic, Middle Aged, Neoplasm Staging, Precancerous Conditions, Survival Analysis, Mice, SCID, Xenograft Model Antitumor Assays, Cell Proliferation, Positron-Emission Tomography, Glucose Transporter Type 1, Sodium-Glucose Transporter 2, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
